MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202621066281 A) filed by Atish Raut; Shivraj Jadhav; Sandip Nighute; Girish Kashid; and Prerana Sharad Pawar on May 26, 2026, for Sustained Release Oral Nano Suspension Composition Comprising Remogliflozin And/Or Pharmaceutically Acceptable Salts Thereof.
Inventors include Atish Raut; Shivraj Jadhav; Sandip Nighute; Girish Kashid; and Prerana Sharad Pawar.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention discloses a pharmaceutical composition comprising nanosuspension of Remogliflozin and pharmaceutically acceptable salts thereof. The pharmaceutical composition comprises Remoglif...